TY - JOUR
T1 - Molecular profiling of driver events in metastatic uveal melanoma
AU - Karlsson, Joakim
AU - Nilsson, Lisa M
AU - Mitra, Suman
AU - Alsén, Samuel
AU - Shelke, Ganesh Vilas
AU - Sah, Vasu R
AU - Forsberg, Elin M V
AU - Stierner, Ulrika
AU - All-Eriksson, Charlotta
AU - Einarsdottir, Berglind
AU - Jespersen, Henrik
AU - Ny, Lars
AU - Lindnér, Per
AU - Larsson, Erik
AU - Olofsson Bagge, Roger
AU - Nilsson, Jonas A
PY - 2020/12/1
Y1 - 2020/12/1
N2 - Metastatic uveal melanoma is less well understood than its primary counterpart, has a distinct biology compared to skin melanoma, and lacks effective treatments. Here we genomically profile metastatic tumors and infiltrating lymphocytes. BAP1 alterations are overrepresented and found in 29/32 of cases. Reintroducing a functional BAP1 allele into a deficient patient-derived cell line, reveals a broad shift towards a transcriptomic subtype previously associated with better prognosis of the primary disease. One outlier tumor has a high mutational burden associated with UV-damage. CDKN2A deletions also occur, which are rarely present in primaries. A focused knockdown screen is used to investigate overexpressed genes associated withcopy number gains. Tumor-infiltrating lymphocytes are in several cases found tumor-reactive, but expression of the immune checkpoint receptors TIM-3, TIGIT and LAG3 is also abundant. This study represents the largest whole-genome analysis of uveal melanoma to date, and presents an updated view of the metastatic disease.
AB - Metastatic uveal melanoma is less well understood than its primary counterpart, has a distinct biology compared to skin melanoma, and lacks effective treatments. Here we genomically profile metastatic tumors and infiltrating lymphocytes. BAP1 alterations are overrepresented and found in 29/32 of cases. Reintroducing a functional BAP1 allele into a deficient patient-derived cell line, reveals a broad shift towards a transcriptomic subtype previously associated with better prognosis of the primary disease. One outlier tumor has a high mutational burden associated with UV-damage. CDKN2A deletions also occur, which are rarely present in primaries. A focused knockdown screen is used to investigate overexpressed genes associated withcopy number gains. Tumor-infiltrating lymphocytes are in several cases found tumor-reactive, but expression of the immune checkpoint receptors TIM-3, TIGIT and LAG3 is also abundant. This study represents the largest whole-genome analysis of uveal melanoma to date, and presents an updated view of the metastatic disease.
KW - Animals
KW - Cyclin-Dependent Kinase Inhibitor p16/genetics
KW - Female
KW - Gene Dosage
KW - Gene Expression Regulation, Neoplastic
KW - Gene Knockdown Techniques
KW - Humans
KW - Lymphocytes
KW - Lymphocytes, Tumor-Infiltrating/pathology
KW - Melanoma/genetics
KW - Mice
KW - Mutation
KW - Neoplasms, Second Primary/genetics
KW - Prognosis
KW - Sequence Analysis, DNA
KW - Transcriptome
KW - Tumor Suppressor Proteins/genetics
KW - Ubiquitin Thiolesterase/genetics
KW - Uveal Neoplasms/genetics
U2 - 10.1038/s41467-020-15606-0
DO - 10.1038/s41467-020-15606-0
M3 - Article
C2 - 32313009
SN - 2041-1723
VL - 11
SP - 1894
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 1894
ER -